Skip to main content
Caplight Logo









Biologix

Biologix

Private
São PauloHealthcare & Life Scienceshttps://biologix.com.br

Last Round

Seed

May 2, 2024

Total Funding Raised

$1.96M

Company Overview

Biologix operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Seed round in May 2024.

Biologix is a healthtech company that develops and produces sleep test equipment for at-home diagnosis of sleep disorders like sleep apnea.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Biologix Comparables

Compare Biologix with similar companies based on industry and business-model similarity.

Biologix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SleepImage
83%
Wesper
81%
Huxley Medical, Inc.
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Biologix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 2, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Filipe Vilela Soares

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Biologix Investors

Notable investors and investment history

Biologix investors
InvestorRounds
Kortex VenturesSeed
FAPESPGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 71% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Biologix Filings

Explore SEC and related filing metadata, where available.

Biologix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Biologix's valuation, stock price, and market status.

Is Biologix a public or private company?

Biologix is a private company.

What is the current stock price of Biologix?

Biologix is a private company, so its shares have no public market price. Caplight tracks Biologix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Biologix worth (valuation)?

Valuation information for Biologix is not publicly available.

Can I buy Biologix stock?

Biologix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Biologix's last funding round?

Biologix's most recent funding round was Seed on May 2, 2024.

Who are the main investors in Biologix?

Key investors in Biologix include Kortex Ventures.

Will Biologix IPO soon?

No public IPO plans have been announced for Biologix.

How can I track Biologix secondary market activity?

Caplight tracks bids, offers, and trades in Biologix's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range53
Year Founded2015
Last FundingMay 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?